(505) 254-7784 pchelp@pcsanm.org
  • About Us
    • Mission Statement
    • Our Board
    • Organization Description
  • Contact Us
0 Items
Prostate Cancer Support Association of New Mexico
  • Home
  • Start Here
    • Beginner’s Guide
    • Next Steps
  • Meetings
  • Resources
  • Education & Info
    • Helpful Prostate Cancer-Related Websites
    • NM Cancer Resources & Support
    • News You Can Use
    • For Medical Professionals
  • Annual Conference
  • Newsletters
  • Early Detection
    • Early Detection
    • Free PSA Test
Select Page

Imaging Technique Predicts Risk of Prostate Cancer Recurrence After Treatment

by admin_63069 | Feb 1, 2023 | Related Topics

Prostate specific membrane antigen (PSMA) PET/MRI can determine whether cancer is likely to return within two years after prostatectomy in men recently diagnosed with intermediate or high-grade prostate cancer. 

Experts Evaluate Outcomes for Men with Low-Grade Prostate Cancer Undergoing Radical Prostatectomy

by admin_63069 | Jan 30, 2023 | Related Topics

In this interview, Kevin Shee, MD, PhD, discusses the background key findings of the Journal of Urology study Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy.

Overview on Metastatic Castration-Resistant Prostate Cancer and Available Treatment Options

by admin_63069 | Jan 26, 2023 | Related Topics

Expert oncologists Tanya Dorff, MD, and Elisabeth Heath, MD, FACP, reflect on the current treatment paradigm for patients with metastatic castration-resistant prostate cancer (mCRPC).

How Testosterone Therapy Use in Prostate Cancer Has Evolved

by admin_63069 | Jan 23, 2023 | Related Topics

Based on current studies and anecdotal evidence, many of today’s urologists think it’s relatively safe to administer testosterone replacement in hypogonadal men on active surveillance or in those who have been treated with prostatectomy or cryosurgery.

Prostate Multi-Parametric MRI

by admin_63069 | Jan 19, 2023 | Related Topics

An overview of the steps involved in the clinical application of mpMRI imaging, from image generation to results interpretation and follow-up.

Abiraterone Breakthrough for High-Risk Prostate Cancer

by admin_63069 | Jan 16, 2023 | Related Topics

Is abiraterone (Zytiga) a game changer for men with high-risk prostate cancer? A new study suggests that when combined with other drugs it is.
« Older Entries

What’s New

  • Imaging Technique Predicts Risk of Prostate Cancer Recurrence After Treatment
  • The Surprising Reason for the Decline in Cancer Mortality
  • Experts Evaluate Outcomes for Men with Low-Grade Prostate Cancer Undergoing Radical Prostatectomy
  • Erleada May Slow Prostate Cancer Progression During Active Surveillance
  • Overview on Metastatic Castration-Resistant Prostate Cancer and Available Treatment Options

Disclaimers:

PCSANM provides education, information, and support, not medical advice. Please contact your physician for all your medical concerns. No copyrighted material belonging to others is knowingly used without permission. If any is inadvertently used without permission, please contact our office. Articles are selected from a variety of sources to give as wide a range of content as possible. PCSANM does not endorse or approve, and assumes no responsibility for, the content, accuracy, or completeness of the information presented.

2533 Virginia St. NE, Suite C Albuquerque, NM 87110

Phone: (505) 254-7784
Toll Free: (800) 278-7678
Fax: (505) 254-7786

Email: pchelp@pcsanm.org